STOCK TITAN

PEDEVCO: SGK trust buys $1.91M in common shares

The reported ownership percentages use a PEDEVCO share-count dated September 15, 2026, preceding the October 8 purchase.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

PEDEVCO Corp. (PED) shares were purchased by The SGK 2018 Revocable Trust: the trust bought 147,070 shares in a market transaction on October 8, 2026, at $13.00 per share, for $1,911,910.

The trust reported beneficial ownership of 4,137,543 shares (31.1%). Dr. Simon G. Kukes, the trust’s trustee and beneficiary, reported beneficial ownership of 4,543,790 shares (34.2%), including 150 shares held by his spouse; he disclaimed beneficial ownership of those spouse-held shares except to the extent of his pecuniary interest. The percentages are based on 13,292,013 shares outstanding as of September 15, 2026. The reporting persons said they acquired the securities for investment purposes and may buy or dispose of securities in the future depending on market and other relevant factors.

Filing Explained

Kukes’s reported 4,543,790-share beneficial ownership includes the SGK Trust’s 4,137,543 shares through his trustee relationship, so the two totals overlap rather than represent separate share blocks.

Shares purchased 147,070 shares Market transaction on October 8, 2026
Purchase price $13.00 per share Market transaction on October 8, 2026
Purchase amount $1,911,910 Purchase by The SGK 2018 Revocable Trust on October 8, 2026
Trust beneficial ownership 4,137,543 shares The SGK 2018 Revocable Trust; 31.1% of the class
Kukes beneficial ownership 4,543,790 shares Dr. Simon G. Kukes; 34.2% of the class
Shares outstanding 13,292,013 shares As of September 15, 2026; basis for the reported ownership percentages
beneficially owned regulatory
"aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power 4,137,543.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 4,137,543.00"
pecuniary interest financial
"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PED shares did The SGK 2018 Revocable Trust buy, and at what price?

The trust purchased 147,070 PEDEVCO common shares in a market transaction on October 8, 2026, at $13.00 per share, for $1,911,910.

How many PED shares do The SGK 2018 Revocable Trust and Simon G. Kukes report owning?

The SGK 2018 Revocable Trust reported beneficial ownership of 4,137,543 shares (31.1%), and Dr. Simon G. Kukes reported 4,543,790 shares (34.2%). The percentages are based on 13,292,013 PEDEVCO shares outstanding as of September 15, 2026. Kukes’s reported amount includes 150 shares held by his spouse, whose shares he disclaimed beneficial ownership of except to the extent of his pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates





70532Y402

(CUSIP Number)
Dr. Simon G. Kukes
575 N. DAIRY ASHFORD,, ENERGY CENTER II, SUITE 210
HOUSTON, TX, 77079
713-221-1768

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
10/08/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(13) Based on 13,292,013 shares of common stock issued and outstanding as of September 15, 2026, as set forth in the Registration Statement on Form S-8 filed by the Issuer with the Securities and Exchange Commission on September 15, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
(8)(10)(11) Includes 150 shares of common stock held by Dr. Kukes' spouse. (13) Based on 13,292,013 shares of common stock issued and outstanding as of September 15, 2026, as set forth in the Registration Statement on Form S-8 filed by the Issuer with the Securities and Exchange Commission on September 15, 2026.


SCHEDULE 13D


SGK 2018 REVOCABLE TRUST
Signature:/s/ Dr. Simon G. Kukes
Name/Title:Dr. Simon G. Kukes, Trustee
Date:10/12/2026
KUKES SIMON G
Signature:/s/ Dr. Simon G. Kukes
Name/Title:Dr. Simon G. Kukes
Date:10/12/2026

Keep reading